WVE
NASDAQStockWave Life Sciences Ltd.
$12.95-0.40 (-3.00%)
52-Week Range
$5.48
$21.31
Key Stats
Market Cap
2.4B
P/E Ratio
—
Dividend Yield
—
Beta
-1.66
Volume
2.2M
Avg Volume
2.3M
Performance
1M
+5.28%
3M
-17.13%
6M
+95.75%
YTD
-16.30%
1Y
+31.27%
3Y
+226.41%
5Y
+38.06%
Price Chart
ETF Exposure
WVE is held by 81 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GNOG.L | Global X - Genomics & Biotechnology UCITS ETF | 1.64% |
| GNOM.L | Global X - Genomics & Biotechnology UCITS ETF | 1.64% |
| GNOM | Global X - Genomics & Biotechnology ETF | 1.48% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.33% |
| OZEM | Roundhill Investments - GLP-1 & Weight Loss ETF | 0.82% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.79% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.62% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.59% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.53% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.43% |
| IWC | iShares Micro-Cap ETF | 0.34% |
| HELX | Franklin Genomic Advancements ETF | 0.29% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.27% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.18% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.18% |
| IBB | iShares Biotechnology ETF | 0.17% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.12% |
| NUSC | Nuveen ESG Small-Cap | 0.11% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.11% |
| IWO | iShares Russell 2000 Growth ETF | 0.10% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.09% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.09% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.08% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.07% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.07% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.07% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.06% |
| IWM | iShares Russell 2000 ETF | 0.06% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.06% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.05% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.05% |
| RSSL | Global X - Russell 2000 ETF | 0.05% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.05% |
| VTWO | Vanguard Russell 2000 ETF | 0.05% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.05% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.04% |
| UWM | ProShares - Ultra Russell2000 | 0.04% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.03% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.03% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.02% |
| VHT | Vanguard Health Care ETF | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | 0.02% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.02% |
Page 1 of 2Next
About WVE ETF Exposure
Wave Life Sciences Ltd. (WVE) is held by 81 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, WVE is a widely held institutional stock. The stock currently trades at $12.95. Investors can gain exposure to WVE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold WVE, sorted by portfolio weight.